ViperMed - Patient education

Congratulations! This Entry has been selected as a semifinalist.

ViperMed - Patient education: Empowering people worldwide through comprehensible education based in evidence.

UruguayChile
Year Founded:
2013
Organization type: 
for profit
Project Stage:
Scaling
Budget: 
$500,000 - $1 million
Project Summary
Elevator Pitch

Concise Summary: Help us pitch this solution! Provide an explanation within 3-4 short sentences.

ViperMed is a patient tele-education platform that empowers our customers: hospitals, clinics, insurances, governments and particulars to educate their patients with curated educative programs delivered by mobile apps with didactical videos that are based clinical evidence provided by BMJ & others.

WHAT IF - Inspiration: Write one sentence that describes a way that your project dares to ask, "WHAT IF?"

What if everyone in the world could have access to the most prestigious patient education in the world in order to improve the life quality?
About Project

Problem: What problem is this project trying to address?

Health services collapsed, high rate of unnecessary consultations, re incidences and lack of patient adherence to medication / treatments are caused by bad patients self-care.Patient Education must be the first point of care, but doctors don’t have time to educate. 90% of people search for patient education over internet(is the top search topic in google) bout the information there is not always accurate.

Solution: What is the proposed solution? Please be specific!

With ViperMed any customer can prescribe educational plans to their patients making use of our education platform.The most innovative is that we offer curated educative programs that came from the most important health institutions in the world(Our Partners).We create value to our customers providing them first class educative contents plus an innovative channel to educate their patients.Our partners provide us the education in text books and papers and we convert them in didactical videos and behavioral change program.All the content from our partners are protected by intellectual property, and we own distribution right(share revenue model) making big entrance barriers for our competitors. BMJ.com(partner) provide us 200 educative programs

Awards

Social entrepreuner by MIT (TR35 Award), Social entrepreuner by IDB, Social enrepeuner by Iberoamerican Summit, Young entrepreuner by United Nations(UNFPA), StartupChile, Microsoft, Protic, Proexport, ANII, Play and Win Award by 3M corporation, i3Latam
Impact: How does it Work

Example: Walk us through a specific example(s) of how this solution makes a difference; include its primary activities.

The "Yo Mujer corporation" is a client that decided to work with ViperMed to reach 10.000 woman that has breast cancer in Chile where the geography difficult a lot the chance for the patients to travel to the capital to receive education. So with ViperMed they are developing 2 strategies to approach the patients. 1- Delivering online education through the database, so each woman receive access to ViperMed in order to receive education about how to manage the pathology. 2- Each educator in the client has access to our ViperMed prescription app and from the palm of the hand can sand access to any new patient, making the impact even more exponential. at the moment 400 patients have received education and the project just started 3 weeks ago!

Impact: What is the impact of the work to date? Also describe the projected future impact for the coming years.

ViperMed have 11 health institutions in Uruguay, Chile, Spain and Colombia with more than 4000 patients educated in Diabetes, Obesity, Hypertension and Breast Cancer. Also have 400 individual users registered (Therapists and individual professionals that want to educate their partners). We have signed contracts with 7 Medical education partners that provide us licenses to deliver more than 10.000 educative contents.Our Most important partner is the British Medical Association, BMJ.com . ViperMed sold 60.000 dollar in last 12 months. We are developing business with UNICEF, UNFPA, Health Ministry of Uruguay and IDB. We are executing several projects: Diabetes: providing education to 3000 patientes. Obesity: providing education to 500 patients. Hypertension: providing education to 1000 patients. Breast Cancer: providing education to 400 patients. Sexuality: 3000 youngs.

Spread Strategies: Moving forward, what are the main strategies for scaling impact?

Chile, Uruguay, Colombia and Mexico are our target market for next 12 months.This market is composed by those that need to educate patients: >100 Health Insurances. >4000 Hospitals & Clinics. >4 Ministries of Health(Governments). >20 Governmental Agencies related to health. >40.000 individuals. >300 NGO’s related to health. Market size: 31.3 Billon dollar market with a growing rate of 7% annually.Everything is happening around health(weareables, big players, EHR’s) We reach customer through:Online Advertising, Partnerships with EHR’s companies, direct sales and conferences.
Sustainability

Financial Sustainability Plan: What is this solution’s plan to ensure financial sustainability?

Our pricing model goes from 250 to 1500 USD/month depending on the number of patients for the "campaigns product". Also we have a pricing for the "prescription app" that goes from 9 to 3 USD per mont per educator. For example an institution that want to educate 1500 patients per year pay 15.000 dollars per year with the campaign solution. A client that have 100 educators that prescribe diabetes courses pay 5 dollar per educator/month.

Marketplace: Who else is addressing the problem outlined here? How does the proposed project differ from these approaches?

Health institutions don’t generate educative materials because education isn’t their core business.There are many web resources that provide text education about health(mostly in English)and also many printed leaflets that some hospitals provide.ViperMed provides educational content based on clinical evidence that are produced by the most relevant medical institutions in the world.We have substitutes but our technology combined with private intellectual property over medical contents has a great deferential that rises entrance barriers for those companies that want to compete ViperMed.
Team

Founding Story

Six years ago I broke my leg, and during mi rehab process i could learn that education is very important to know how to take care when you are ill. In my case no one helped me, I felt alone. After my experience i could see that many of my friends had the same problem once they had a health problem so i decided to do something about it. After being working during a year with the idea i could find out that 90% of people search for information related to their heatl condition over internet, but only 10% of them can access to the right and information. With support of my government and the team I could approach this problem in the world that is huge!

Team

Founding team: Meet the team! https://vimeo.com/89970422 Ignacio Oliveri (Universidad ORT Uruguay, Systems Analyst): CEO of ViperMed.(www.vipermed.uy). Awarded by MIT with TR35 prize, as one of the world's top innovators under the age of 35 in 2013, also awarded as the social innovator.10 years of experience in business development and Internet technology. Co-founder of Kizanaro Sport Technology (www.kizanaro.com). He have raised more than U$D 500,000 investment of state and private funds. He have the experience to make ViperMed grow. Diego Delfino (Sweden,Stockholm University, Engineer): CTO of ViperMed. Senior Web Developer with extensive experience in web programming and client communication. He has 14 years of experience working with online solutions in several projects around the world including Europe, South America and Africa. He is the Technical Man in ViperMed and he makes ViperMed products incredibly great products. Martin Amoroso (Ort University Uruguay, Business communication/Marketing): CMO of ViperMed. He has 4 years o proven experience in Meetlife company, Life insurance. In different roles: Account Executive, Assistant Manager, Team Leader (leading 40 people). He brings a strategic business vision based on the development of ambitious objectives. He is the commercial man in the company, the one who fight day by day to attract new customers and develop the existing ones. ViperMed has 8 full time employes: Ignacio Oliveri: CEO, since august 2012 Diego Delfino: CTO, since april 2013 Martin Amoroso: Business developer, since september 2013 Martin Nuñez: Contents producer, since march 2014 Cecilia Medina: Multimedia animator, since september 2015 Alejandro Tocar: Software Developer, since January 2015 Joaquin Fernandez:Contents producer, since march 2015 Virginia Alvarez: Ux expert, since september 2012 Meet them: https://player.vimeo.com/video/89970422 We have 3 investors: 2 from the healthcare industry and 1 that is an endeavor entrepreneur. While the project grows we will increase the number of employes in sales and marketing. Also in content production to generate more educative contents. The technology team has 2 engineers but can grow up to 5 in next months. The team has the right mix: a deep knowledge in technology group plus a creative content production team that support a very inspired marketing and sales team!
CO-CREATION IDEA: Please offer a brief description of how you imagine a win-win partnership with Boehringer Ingelheim to better serve unmet needs in health. (Hint: Please mention the underlying business model envisioned that would make such a partnership sustainable.)

We both approach Cardiovascular, Diabetes, Oncology, Respiratory, CNS and Virology diseases and we both want to improve the life quality of the final users of our products, the patients. So we are very complementary and we can join efforts to do so. We can add our technology and model to increase the channel that you use to reach your clients and the final users of your products. Imagine that together we can empower thousand of health professionals to prescribe education to patients making impact over million of people. We both will win, you can reinforce the added value and increase the institutional relationships with key accounts and we at the same time can increase our impact and expertise . Together we will win helping more people.

NEEDS: Based on you response above, please specify which of the following resources, operations or expertise by Boehringer Ingelheim you imagine leveraging to actualize the proposed co-creation opportunity. Please check all that apply. (Hint: while financing is often critical to scale, we are also interested in understanding what other assets or expertise could be leveraged).

Distribution Channels, Specific Disease Expertise, Relationships/New Contacts, Marketing/Communications Support, Access to Capital.

EXPLANATION OF NEEDS: Please explain your choices in more detail.

We are very interested in reach our ambitious mission: reach a billon of patients. So the most important for our company is to co create solutions and channels to reach them in a short period of time. So you have a really huge expertise putting your products in the hands of those that need them, we want to be with you reaching them to thorough your channels. At the same time we would need support from your experts in diseases to understand better the problem with a global vision.

OFFER: What are the main assets you may contribute in a co-creation partnership with Boehringer Ingelheim that would better serve unmet needs in health?

Deep understanding of an unmet need in a specific market/context, Access to and established trust with customers/beneficiaries, Insights into behavior change.

FOCUS AREAS: Which of the following best describes the main focus of your project? (select all that apply)

Holistic solutions that work across the entire care continuum (including education, prevention, detection, treatment, management, follow-up), Remote care solutions for health management, treatment, and diagnosis, Packaging of health products and services to address needs currently unmet.

SECONDARY ENTRY FORM
Please share what your organisation and Boehringer Ingelheim will Co-Create together

To empower patients we will co-create a digital therapeutic solution focused in COPD and using as a testing market Canada the English/French speaking population and the non-English/French speaking population.

During many weeks we have been working closely with some BI stakeholders, investigating reports generated by BI and also talking with many international experts, that we have relationship, to co create an initiative that aim to change the role of patients in the health system, empowering them through education.

This initiative is supported by a very powerful technology and a set of educative programs in many languages and cultural aspects. To educate patients we will use education based in clinical evidence and this education will be delivered by mobile phones and using audiovisual animations.

This co creation initiative will be a status quo changer and will impulse a social revolution that is happening: the patient revolution where patient is in the center of the stage and make better decisions taking control of his own health.

Please specify what your Co-Creation will result in:

a new product, a new distribution channel, a new market/customer group, other (please explain below).

If you selected "other" above, please explain:

Helping non-English/French speaking COPD patients in Canada truly understand their condition and impacting the whole society.

Please provide a 1-2 sentence summary of your Co-Creation idea

BI in partnership with ViperMed will develop a mobile patient education tool that can be accessible to patients at the time of diagnosis and in their language of choice.

Together we will co-create a digital patient education solution for COPD patients aimed in the short term to:
• help patients understand the disease.
• maximize the adherence to treatments by understanding their medication(s) and
• reinforce the self-care behavior related to their chronic disease.
In the mid/long term to:
• reduce the healthcare costs,
• decrease unnecessary revisits to primary care hospitals and clinics.

Collaborative discussions with Noora Health has taken place and ViperMed educative programs that are relevant to educating patient and their families in rural India will be taken and used by Noora Health to bring awareness to these communities.

How does this project link to the core mission of your organisation?

ViperMed is a patient education company, that specializes in projects that focuses to empower patients through education. Currently, we are working with 11 clients educating more than 4500 patients. In fact, ViperMed is working with The Ministry of Health of Uruguay with smoking cessation programs as well. So, developing a patient education tool for COPD aligns directly with our company’s mandate as well as active involvement on WHO public policy initiatives involving digital therapeutic program on smoking cessation.

Beyond social impact, how does this project link to Boehringer Ingelheim’s core business?

COPD is one of BI’s core therapeutic focuses worldwide. BI has a strong foothold on bronchodilator treatments and with the help of ViperMed, BI can be actively engaged on patient-centric initiatives such as this one, which is a patient education solution that would ultimately lead to patient behaviour changes and changes to patient-doctor interactions. By collaborating with ViperMed, BI will empower their patients by helping them to better understand their health condition, and also increase patient adherence to the treatments prescribed by doctors. In Canada, the bronchodilator business is about 1.2 billion dollars, of which COPD roughly is 50% of this and maintaining competiveness in this market requires BI to put more emphasis on patient needs and patient education is a huge component of this.

What are the specific inputs and actions that each side will contribute to this Co-Creation idea based on each of your unique competencies and experiences?

○ My organization will contribute:

-Expertise in the development of the mobile/PC/Tablet technology to implement the patient education program following an understanding of patient needs.
-Technological platforms that can enable telemedicine and patient monitoring in order to address patient adherence needs.
-Expertise in the development of curated audio-visual patient educative contents from top knowledge generators in the world (BMJ as sample).
-Expertise in the implementation and measurement of exponential and social impact projects.

○ Boehringer Ingelheim will contribute:

-Medical knowledge (both internally and via affiliations with external members of the medical community) worldwide
-Capital means to roll out projects that align directly with BI corporate strategy
-Patient- focused initiatives are high on BI's company mandate both in Canada and globally
-A global channel to make our initiative a reality.

Please describe the potential revenue model for this Co-Creation idea.

With this initiative we will be approaching COPD and each hospital will have the chance to educate their patients about how to manage the pathology. We will generate commercial relationships with each hospital that can be a ViperMed client adopting one of our 180 different educative programs with their population in the same way they will be doing with COPD. With each client we can make specific proposals based in the needs that they have and using an upselling strategy of our commercial team and strategy, offer them more ViperMed products that may be complementary with the COPD educative program.

What possible risks or challenges do you foresee?

Empowering patient through knowledge can be negatively viewed by conservative medical professionals as they may fear that patients may not have the capacity to fully understand their health and therefore, more information could result in a negative impact. There is an increasing trend for patient ownership of their health and for family members to take on caregiver roles to assist in the overall healthcare. By taking this into consideration, ViperMed’s expertise and experience in patient education, will be of great benefit to mitigate these risks and offer solutions that have been shown to be effective.

The implementation of this initiative has risks in terms of personal data protection laws, there are more advanced countries but many countries have not adapted a solution to support the security protocols.

Finally gathering evidence about the therapeutic impact is a challenge that we will need to approach in order to empower the replication of the initiative worldwide.

Is there anything else you would like to share about your Co-Creation idea?

Since last 2 years many pharmaceutical companies like Novartis, GlaxoSmithKline and Pfizer approached us concerning that they need to educate the patients. In 2013, we participated in an initiative from Novartis providing education to patients that had received a liver transplant. We know that patient education is an excellent complementary to the treatment, and many laboratories showed us that this is a must have.

90% of patients search education over Internet so providing a trusted education in a proactive way will not only increase the relationship with customers but also increase the patient compliance and revenues.

Since ViperMed born we used the prototype as a core element and in this case we decided to implement a prototype:
Please watch:
- The attachment: FutureOfMedication.jpg
-The multi language Video: https://vimeo.com/138415323
-A COPD educative video sample: https://vimeo.com/149711610

How much input do you hope to receive from Boehringer Ingelheim?

I’d like to implement together, other (Please explain below).

If you selected "other" above, please explain:

BI can provide us a very valious market information that may help us to focus our growing efforts.

Besides Boehringer Ingelheim, what other types of partners might be valuable to carrying out your Co-Creation idea, and why?

We will generate partnerships for the worldwide approach and also in each country that we implement the initiative. In each country will partner with medical associations to spread out the solution and to make it available to all the doctors, also is important to partner with the Ministry of Health of each country to align our initiative with their public policies with. At a higher level we will develop partnerships with trusted institutions that provide the education contents (like BMJ our partner) and also to have the explicit interest of the World Health Organization through their “be Mobile” initiative.